The Biosafe diabetes risk assessment is a two-part process comprised of an immediate fasting glucose reading and a mail-in laboratory analysis for hemoglobin A1c, a blood glucose marker for the previous ninety-day period. Samples for both tests can be either professionally collected or self-collected through the use of a simple finger-nick collection kit. Taken in combination, these two results are said to become a reliable indicator of diabetes or a pre-diabetes condition.
Jack Maggiore, president of Biosafe Laboratories, said: “The Biosafe diabetes risk assessment is a common-sense approach to early detection of a potentially dangerous condition.”